Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioTime Appoints CFO

This article was originally published in Scrip

Executive Summary

BioTime Inc., a company focused on pluripotent stem cell technology, has appointed Russell Skibsted chief financial officer (CFO). Skibsted joins BioTime from Proove Biosciences where he was CFO and previously served as senior vice president (SVP), CFO and secretary of Aeolus Pharmaceuticals. Skibsted was also SVP and chief business officer of Spectrum Pharmaceuticals and CFO of Hana Biosciences.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC063749

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel